Global menu

Our global pages

Close

The law firms involved in the acquisition of the Agfa- Gevaert Group's healthcare IT business

  • Italy
  • General

14-05-2020

Eversheds Sutherland, with a team led by the executive senior partner Marco Franzini, the partner Alessandro Vischi, the associate Angela Costanzo and the trainee Francesca Sergiano, has assisted Giorgio Moretti (founder and shareholder of the Dedalus Group with a stake of 25%, as well as chairman of Dedalus Holding) and his holding company Health Holding Company, in (i) the negotiation and definition of the corporate governance agreements with the French fund Ardian (shareholders’ agreements, companies’ by-laws, management agreements) in the context of the acquisition of a part of the healthcare IT business of Agfa-Gevaert, (ii) the de-merger of Health Holding Company for the minority investment of Three Hills Capital Partners and (iii) in the negotiation and definition of the agreements for the investment of this fund and of the corporate governance of Health Holding Company.

 

With completion of the acquisition of part of the healthcare IT business of Agfa- Gevaert, the Dedalus Group, participated by the investment company Ardian and Health Holding Company, takes an important step for the European consolidation of the sector and becomes the first European company in clinical and healthcare IT systems, as well as one of the first in the world. With a unique industrial capacity in the sector, as from 5 May 2020, the Dedalus Group has become the largest company in the sector with a presence in over 30 countries worldwide and with 5,000 hospitals, 5,000 laboratories and over 2 million professionals who treat hundreds of millions of patients every day.

 

The other law firms involved in the transaction are Clifford Chance, Gattai Minoli Agostinelli & Partners, Simmons & Simmons, Latham & Watkins, Giovanelli e associati, Gianni Origoni Grippo & Partners and Gitti & Partners

Disclaimer

This information is for guidance purposes only and should not be regarded as a substitute for taking legal advice. Please refer to the full terms and conditions on our website.

< Go back

Print Friendly and PDF
Register to receive regular updates via email.